Ipriflavone does not alter bone apatite crystal structure in adult male rats

Calcified Tissue International

Volumn 59, Issue 6, 1996, Pages 496-499

  Ghezzo, C ^a   Civitelli, R ^b   Cadel, S ^c   Borelli, G ^c   Maiorino, M ^c   Bufalino, L ^c   Bongrani, S ^c  

^a UNIVERSITY OF SIENA   (Italy)

^b WASHINGTON UNIVERSITY   (United States)

^c CHIESI FARMACEUTICI S P A   (Italy)

Author keywords

Bone crystals; Bone quality; Ipriflavone; Mineral analysis; X ray diffraction

Indexed keywords

APATITE; IPRIFLAVONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLIZATION; MALE; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; RAT; X RAY DIFFRACTION;

EID: 0029906898     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00369217     Document Type: Article

References (24)

1. Burnell JM, Teubner EJ, Miller AG (1980) Normal maturational changes in bone matrix, mineral, and crystal size in the rat. Calcif Tissue Int 31:13-19
2. Posner AS (1969) Crystal chemistry of bone mineral. Physiol Rev 49:760-792
3. Termine JD, Eanes ED (1972) Comparative chemistry of amorphous and apatitic calcium phosphate preparations. Calcif Tissue Res 10:171-197
4. Eanes ED, Reddi AH (1979) The effect of fluoride on bone mineral apatite. Metab Bone Dis Rel Res 2:3-10
5. Grynpas MD (1995) Fluoride effects on bone crystals. J Bone Miner Res 5:S169-S175
6. Shinoda H, Adamek G, Felix R, Fleisch H, Schenk R, Hagan P (1983) Structure-activity relationship of various bisphosphonates. Calcif Tissue Int 35:87-99
7. Fleisch H, Russell RGG, Bisaz S, Mühlbauer RC, Williams DA (1970) The inhibitory effect of phosphonates on the formation of calcium phosphate crystals in vitro and on aortic and kidney calcification in vivo. Eur J Clin Invest 1:12-18
8. Fleisch H (1991) Bisphosphonates: pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone diseases. Drugs 42:919-944
9. Yamazaki I, Shino A, Shimizu Y, Tsukuda R, Shirakawa Y, Kinoshita M (1986) Effect of ipriflavone on glucocorticoid-induced osteoporosis in rats. Life Sci 38:951-958
10. Foldes I, Rapcsak M, Szoor A, Gyarmati J, Szilagy T (1988) The effect of ipriflavone treatment on osteoporosis induced by immobilization. Acta Morphol Hung 36:79-93
11. Shino A, Matsuo T, Tsuda M, Yamazaki I, Tsukuda R, Kitazaki T, Shiota K, Okada H, Yoshida K (1986) Effect of ipriflavone on bone and mineral metabolism in the streptozotocin diabetic rats. J Bone Miner Metab 3:27-37
12. Agnusdei D, Bufalino L, Gennari C (1993) Effects of ipriflavone on bone mass and bone turnover in postmenopausal women with low bone mass. In: Christiansen C, Riis BJ (eds) Proceedings 1993: IV International Symposium on Osteoporosis. Handelstrykkeriet, Aalborg, Denmark, pp 467-470
13. Passeri M, Abate G, Costi D, Biondi M, Di Peppe C, Bufalino L, Castiglione GN (1993) Ipriflavone in the treatment of established postmenopausal osteoporosis. In: Christiansen C, Riis BJ (eds) Proceedings 1993: IV International Symposium on Osteoporosis. Handelstrykkeriet, Aalborg, Denmark, pp 463-466
14. Gambacciani M, Spinetti A, Cappagli B, Taponeco F, Felipetto R, Parrini D, Cappelli N, Fioretti P (1993) Effects of ipriflavone administration on bone mass and metabolism in ovariectomized women. J Endocrinol Invest 16:333-337
15. Brandi ML (1992) Flavonoids: biochemical effects and therapeutic applications. Bone Miner 19:S3-S14
16. Brandi ML, Gennari C (1993) Ipriflavone: new insights into its mechanisms of action on bone remodeling (letter). Calcif Tissue Int 52:151-152
17. Civitelli R, Abbasi-Jahromi SA, Halstead LR, Dimarogonas AD (1995) Ipriflavone improves bone density and biomechanical properties of adult male rat bones. Calcif Tissue Int 56: 215-219
18. Weiner S, Price PA (1986) Disaggregation of bone into crystals. Calcif Tissue Int 39:365-379
19. Termine JD, Eanes ED, Greenfield DJ, Nylen MU (1973) Hydrazine-deproteinated bone mineral. Calcif Tissue Res 12: 73-90
20. Riggs BL, Hodgson SF, O Talion WM, Chao EYS, Wahner HW, Muhs JM, Cedel SL, Melton LJ III (1990) Effect of fluoride on the fracture rate in postmenopausal women with osteoporosis. N. Engl J Med 322:802-809
21. Pak CYC, Sakhaee K, Zerwekh JE, Parcel C, Peterson R, Johnson K (1989) Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures. J Clin Endocrinol Metab 68:150-159
22. Zipkin I, Posner AS, Eanes ED (1962) The effect of fluoride on the X-ray-diffraction pattern of the apatite of human bone. Biochim Biophys Acta 59:255-258
23. Schraer H, Posner AS, Schraer R, Zipkin I (1962) Effect of fluoride on bone "crystallinity" in the growing rat. Biochim Biophys Acta 64:565-567
24. Grynpas MD, Acito A, Dimitriu M, Mertz BP, Very JM (1992) Changes in bone mineralization, architecture and mechanical properties due to long-term (1 year) administration of pamidronate (APD) to adult dogs. Osteoporosis Int 2:74-81